Navigation Links
Angeion Corporation Reports First Quarter Fiscal Year 2012 Operating Results
Date:2/28/2012

SAINT PAUL, Minn., Feb. 28, 2012 /PRNewswire/ -- Angeion Corporation (NASDAQ: ANGN) today reported financial results for its first quarter fiscal 2012 ended January 31, 2012.

First Quarter Highlights:

  • Revenues of $7.1 million, comparable to the first quarter of 2011;
  • Service revenue improved 19% to $1.1 million, compared to $909,000 in last year's first quarter;
  • GPO (group purchasing organization) revenue during the first quarter increased 321% to $1.4 million, compared to $332,000 in the comparable quarter;
  • Recurring revenue in the first quarter increased 14% to $3.9 million and accounted for approximately 55% of total revenue in the quarter;
  • Gross margin for the first quarter remained solid at 56.4%;
  • Domestic sales increased to $5.7 million, a 10% increase over the prior year's first quarter;
  • Strong balance sheet with $9.2 million in cash and investments, over $13 million of working capital and no long-term debt; and
  • Addition of RTD™ (Real-Time-Diffusion™) MultiGas Technology™ to our product family.

    • Angeion reported revenue of $7.1 million compared to $7.1 million in the first quarter of fiscal 2011. For the first quarter, domestic sales increased 10% to $5.7 million, compared to $5.2 million in the previous year's first quarter and international sales decreased by 26% to $1.4 million, versus $1.9 million in last year's comparable first quarter. During the first quarter, equipment, supplies and accessories sales decreased by 2.7% to $6.0 million, compared to $6.1 million during last year's period. Service revenue increased 19% to $1.1 million, versus $909,000 in last year's first quarter.   Angeion reported net loss of $249,000, or ($0.07) per diluted share, versus net loss of $324,000, or ($0.09) per diluted share, in the comparable quarter last year.


    '/>"/>

    SOURCE Angeion Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Angeion Corporation to Report Third Quarter Fiscal Year 2011 Financial Results on Thursday, September 1, 2011
    2. Angeion Corporation Reports Third Quarter Fiscal 2011 Operating Results
    3. Angeion Corporation to Report Fourth Quarter and Fiscal Year 2011 Financial Results on Friday, December 16, 2011
    4. Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results
    5. Angeion Corporation to Report First Quarter Fiscal 2012 Financial Results on Tuesday, February 28, 2012
    6. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
    7. CEL-SCI Corporation Releases Letter to Shareholders
    8. Alfacell Corporation to Present at UBS Global Life Sciences Conference
    9. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
    10. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
    11. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/23/2013)...  Ameritox, the nation,s leader in pain medication ... to become part of its Urine Drug Monitoring ... and improve the clinical outcomes for injured workers. ... manager in the workers, compensation industry, has used ... management strategy for several years. By establishing a ...
    (Date:5/23/2013)... 2013  BioElectronics Corporation (OTC Pink: BIEL), the maker ... the FDA panel meeting for non-thermal shortwave diathermy: ... Shortwave Therapy Meeting was held on May 21, 2013 ... focus of the meeting was very narrow, in that ... on the application of non-thermal shortwave diathermy for the ...
    (Date:5/23/2013)... , May 23, 2013  CAS Medical Systems, Inc. (NASDAQ: ... for non-invasive patient monitoring, today announced that Thomas ... present at the 2 nd Annual Marcum MicroCap Conference ... in New York City . ... in the Estate 10 room and will be available via ...
    Breaking Medicine Technology:Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2
    ... U L URUI nc. (NYSE Amex: ... an abbreviated 510(k) application with the U.S. Food and Drug ... and mitigation of pain. The principal data supporting ... to Acquacel® Ag in skin graft donor sites. This amended ...
    ... 16, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: ... "Company"), a leading China-based pharmaceutical and biotechnology ... that its wholly-owned contract research subsidiary, Shanghai ... agreement with Shenogen Pharma Group to develop ...
    Cached Medicine Technology:ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 2ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 3ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 4Shanghai ChemPartner Announces Being Selected as Antibody Service Partner by Shenogen Pharma Group 2
    (Date:5/23/2013)... 2013 In his pulse-quickening novel, “The AIDS ... “Do you trust your government?” , In the “The AIDS ... route to London ’s Heathrow Airport. His American colleague, ... waiting for him to arrive at his Sierra Nevada ... Alan has doubts about the government’s report. When Alan learns ...
    (Date:5/23/2013)... Dr. Damon Huffman of Huffman Family Dentistry ... disease a revolutionary new treatment method with the Laser Assisted ... who suffer from periodontal disease, and many of them do ... Huffman is hoping that LANAP will encourage many of those ... , Periodontal disease can cause gums to recede and ...
    (Date:5/23/2013)... Da Vinci surgical robot maker Intuitive Surgical defeated negligent ... 23, according to Bloomberg.* The Rottenstein Law Group LLP, ... expresses disappointment in the ruling but encourages those looking ... single verdict as representative of all da Vinci lawsuits. ... Intuitive Surgical Inc.; 09-2-03136-5, Superior Court, Port Orchard, Wash.) ...
    (Date:5/23/2013)... Memorial Day Focus Spotlight on Military Chaplains Transitioning ... of the U.S. Military for more than 200 years. ... men and women will be honored for their dedication ... As veterans transition to civilian life, there is an ... world. , Marketplace Chaplains, America’s original and largest ...
    (Date:5/23/2013)... Live Lead Pros , with ... best business lead solution via its smart solution ... solution features Free Web Based Account Management, Database ... and "Automatic Transfer Retry". The company has recently ... management system. , Its Free Database Usage offers ...
    Breaking Medicine News(10 mins):Health News:New Book “The AIDS Covenant” by Roy Harris Delivers Intriguing, Captivating Story 2Health News:Humble, TX Dentist, Dr. Damon Huffman Now Offers Laser Periodontal Disease Treatment to Gum Disease Patients 2Health News:Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial 2Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 2Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 3Health News:Live Lead Pros Announces The Benefits of Comprehensive Campaign Delivery and Management System 2
    ... celebrate the silver jubilee of The Art of Living in ... free' America initiative;// is being launched by Indian spiritual guru ... to be attended by over 2,500 people along with 20 ... to foster human values such as compassion, friendliness, a sense ...
    ... BULLYING ,In the broadest study of bullying and sexual ... times more likely to report having been bullied //than ... were twice as likely, after adjustment for age and ... a population vulnerable to bullying,' says researcher Elise Berlan, ...
    ... be hailed as a leprosy-free zone by health administrators worldwide. ... more are suffering// from the terrifying disease. ,But ... point out. And the stigma the disease carries with it ... an ancient, much feared disease. But although it is infectious ...
    ... activists and film personalities have expressed concern for millions ... to fight it. ,Around 78,000 children in ... of them may die in the next five years, ... who are visiting the villages in Madhya Pradesh to ...
    ... able to predict whether a person is likely to have ... by Dr. M. Balasubramanyam and Dr.V.Mohan at the Madras Diabetes ... who have Type 2 diabetes have much shorter telomeres1 and, ... could indicate their susceptibility and help them to alter their ...
    ... and Drug Administration (FDA) today announced that manufacturers of ... disease, will voluntarily remove// these drugs from the market ... heart valves. ,The products being withdrawn are ... Pharmaceuticals, and two generic versions of pergolide manufactured by ...
    Cached Medicine News:Health News:Children's Hospital Boston Presents at the Society for Adolescent Medicine Annual Meeting 2Health News:MPs Vow to Fight Malnutrition in Madhya Pradesh 2Health News:New Genetic Biomarkers Could Predict Coronary Heart Disease 2Health News:FDA Announces Voluntary Withdrawal of Pergolide Products 2
    ... Vision5L Digital Holter ... or 7-lead, 3-channel,Holter ... signal preview,screen. Fast ... a compact,flash card ...
    ... The CSV-1000CVA20/30 test face provides three contrast levels ... from 20/16 to 20/100. This test is designed ... as associated with contact lens evaluation or due ... the test provide the same contrast and acuity ...
    The CSV-1000SLanC test face provides the same tests as the standard CSV-1000S, except that the acuity test is presented in Landolt C format. , ,This test is very useful when testing patients who cann...
    Contrast sensitivity testing, glare sensitivity testing and ETDRS acuity testing are provided in the self standardized CSV-1000 instrument. Patented photocell circuitry automatically monitors and cal...
    Medicine Products: